α-Amylase Inhibitor Chewable Tablet (previously α-Amylase Inhibitor 2500IU Chewable Tablet) (Marvel Health (Australia) Pty Ltd)
Product Name
α-Amylase Inhibitor Chewable Tablet (previously α-Amylase Inhibitor 2500IU Chewable Tablet)
ARTG details
401793
Date of review outcome
Date of publication
Mar-2026
Outcome
Medicine is no longer permitted to be supplied
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, follow the recommended actions below.
What action should consumers take?
Consider whether this medicine is right for you given that the claims related to inhibition of α-amylase were not substantiated by the sponsor
Review scope
Targeted
Information reviewed
ARTG Record, Evidence, Labels
Issues related to safety
The safety of this medicine was not assessed as part of this review
Issues related to efficacy
The name of this medicine made claims regarding inhibition of α-amylase. However, the sponsor did not hold sufficient evidence to support these claims. The limitations with the evidence included the form, quantity and method of preparation for the herbal ingredient Phaseolus vulgaris (kidney bean) not being relevant to this medicine.
Actions taken during the review
The TGA required the sponsor to correct the issues with this medicine. The sponsor cancelled this medicine and withdrew it from further supply.